https://dihydroartemisinininhi....bitor.com/continuing
A quasi-experimental study included customers with active shot drug usage and definite IE from January 2013 to July 2017 (preintervention team) and from September 2017 to January 2019 (intervention team). The primary upshot of interest had been the 90-day all-cause readmission rate. Additional effects included infection-related readmission rates, in-hospital and all-cause mortality prices, and also the frequency of clients leavi
Like
Comment
Share
